Reading the RIAT Act:
A Call to Publish Unpublished Data


The Restoring Invisible and Abandoned Trials (RIAT) proposal, backed by the British Medical Journal and PLoS ONE last week, calls for the “responsible publication and republication of abandoned studies” by the studies’ original authors within one year, or for all publicly available data for such trials to then be considered publishable by others.

Article →

Of Further Interest:
PLOS ONE welcomes RIAT (Restoring Invisible and Abandoned Trials) Initiative (PLoS ONE)
Restoring invisible and abandoned trials: a call for people to publish the findings (BMJ)
Restoring the integrity of the clinical trial evidence base (BMJ)
Experts: Publish ‘Invisible’ and ‘Abandoned’ Clinical Trials (Medscape)
Restoring Invisible and Abandoned Trials (RIAT) “to correct the scientific record” (

Previous articlePsychiatry’s Oppression of Young Anarchists — and the Underground Resistance
Next articleTapering Off Medications When “Symptoms Have Remitted”:
Does That Make Sense?
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].


  1. Reality check:

    Whose got the muscle to ram this through?

    And if it looks as if its actually Going to be implemented, how long will it be before Senator Foghorn guts it with a rider or amendment to it or some other bill calling it a Protect Intellectual Property Rights issue?

    This is not going to fly. Drug Makers and their Street Vendors have the money and machinery in place to make sure it never gets out of the stocks.

    Look at what Congress did when they got caught up to their eye teeth in Insider Trading shennanigans.

    Report comment